CRISPR Therapeutics AG Common Shares (CRSP) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. Wells Fargo’s estimates were … This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.This signal is rare and, in most cases, gives substantial returns. The chart below shows how a company's share price and consensus price target have changed over time. Get the latest CRISPR Therapeutics AG CRSP detailed stock quotes, stock data, Real-Time ECN, charts, stats and … On October 22, 2020 "Chardan Capital" gave "Positive - Buy" rating for CRSP. Nobody expects what they're predicting now... MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Learn about financial terms, types of investments, trading strategies and more. Average Target Price: 144.06: Number Of Ratings: 19: FY Report Date: 12/2020: Last Quarter's Earnings-1.32: Year Ago Earnings: 0.01: Current Quarter's Estimate-1.27: Current Year's … The price ⦠The price target was set to $170.00 → $210.00. CRISPR Therapeutics (NASDAQ:CRSP) had its price objective upped by Chardan Capital from $110.00 to $166.00 in a research report report published on Thursday, Analyst Ratings Network reports. Based on 17 analysts offering 12 month price targets for Crispr Therapeutics AG in the last 3 months. In a report released today, Alan Carr from Needham assigned a Buy rating to Crispr Therapeutics AG (CRSP â Research Report), with a price target of $170.00.The companyâs shares ⦠On January 12, 2021 "Truist" gave "" rating for CRSP. View our full suite of financial calendars and market data tables, all for free. Based on analysts offering 12 month price targets for CRSP in the last 3 months. CRISPR Therapeutics AG quote is equal to 198.240 USD at 2021-01-20. MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. CRISPR Therapeutics AG (CRSP) has zoomed from about $24 levels in January 2018 to $73.09 as of June 25, 2020, and thatâs a massive appreciation of about 300% in a space of 30 ⦠This price target is based on 16 analysts offering 12 month price targets for CRISPR Therapeutics in the last 3 months. ET by Tomi Kilgore Crisper Therapeutics shares decline on wider-than-expected loss "StockInvest.us" is a research service that provides financial data and technical analysis of publicly traded stocks. Export data to Excel for your own analysis. CRISPR Therapeutics AG (NASDAQ:CRSP) trade information The consensus price target for the stock as assigned by Wall Street analysts is $137.63, meaning bulls need a downside of … CRISPR Therapeutics AG [CRSP] stock Reiterated by Needham analyst, price target now $170 CRISPR Therapeutics AG [NASDAQ: CRSP] gained 12.27% on the last trading session, ⦠This suggests a possible upside of 27.2% from the stock's current price. All stock picks. A number of other equities analysts have also recently weighed in on the stock. Their forecasts range from $21.00 to $72.50. The company currently has a consensus rating of âBuyâ and a consensus price target of $130.79. Of Politics and Stock Prices Jan 17 / MotleyFool.com - Paid Partner Content The Zacks Analyst Blog Highlights: CRISPR Therapeutics, Vertex Pharmaceuticals and Intellia Therapeutics Actually, shares of CRISPR Therapeutics (CRSP Quick Quote CRSP - Free Report) were flying even before the 4-day virtual gathering of scientists and physicians which took place December ⦠Most of the world’s richest investors totally ignore company fundamentals like P/E ratios. Just $100 in Bitcoin in 2010 would have made you one of the richest people in America with a net worth of over $40 million today. With a 5 … Given the current short-term trend, the stock is expected to rise 115.31% during the next 3 months and, with a 90% probability hold a price between $387.80 and $473.00 at the end of this 3-month period. Users should not base their investment decision upon "StockInvest.us". CubeSmart (NYSE: CUBE) Stock is a Smart Pullback Play, Capstone Turbine (NASDAQ: CPST) Stock a Clean Energy Turbine Play, 3D Printing Stocks Offering Another Dimension of Gains, MicroStrategy (NASDAQ:MSTR) Slips on Troubles in Bitcoin. As such, CRSP is trading 3.91% off suggested target ⦠Stock Trading Strategies. The price target … On average, they anticipate Crispr Therapeutics' stock price to reach $48.9167 in the next twelve months. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock. Receive a free world-class investing education from MarketBeat. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. Back in November, Oppenheimer analyst Silvan Turkcan issued a price target of $80 for CRISPR Therapeutics, suggesting at least a 57.1% upside to the stock based on current prices. The average price target is $141.79, with a high forecast of ⦠TheFly.com is reporting that Oppenheimer & Co. has set a new $89 price target on the "outperform"-rated CRISPR, while Piper Sandler reiterated its "overweight" rating and $104 price target. Wells Fargo rated the CRISPR Therapeutics AG (NASDAQ: CRSP) stock âan Equal weightâ and gave the companyâs common stock a price target of $145. Several other equities ⦠CRISPR Therapeutics (NASDAQ:CRSP) had its price target boosted by Truist from $170.00 to $210.00 in a research report released on Tuesday, The Fly reports. Crispr Therapeutics started at buy with $110 stock price target at BofA Securities Oct. 5, 2020 at 11:33 a.m. View today's stock price, news and analysis for CRISPR Therapeutics AG (CRSP). Your losses are our losses too. To see all exchange delays and terms of use please see disclaimer. View IEX’s Terms of Use. View today's stock price, news and analysis for CRISPR Therapeutics AG (CRSP). Canaccord Genuity increased their price objective on shares of CRISPR … In depth view into CRISPR Therapeutics Price Target Upside (Daily) including historical data from 2016, charts, stats and industry comps. The dark blue line represents the company's actual price. View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Learn everything you need to know about successful options trading with this three-part video course. Shares of CRISPR Therapeutics stock opened at $148.41 on Thursday. Please read the full disclaimer here. They now have a $145.00 price ⦠After a Post-Earnings Drop, is it Time to Ride PetMed Express? Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. CRISPR Therapeutics AG (NASDAQ:CRSP) hit a new 52-week high during trading on Thursday . The high price target for CRSP is $210.00 and the low price target for CRSP is $31.00. Stock Trading Strategies. Now people are pouring into cryptos like we haven’t seen in years... but don’t do anything until you see this new warning. featured in The Global Fintech Index 2020 as the top Fintech company of the country. Stock Picks. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. The average price target is $146.07 with a high forecast of $210.00 and a low forecast of $45.00. 7 Electric Vehicle (EV) Stocks That Have Real Juice, 7 Post-Inauguration Stocks to Buy For Under $20, 7 Cryptocurrencies That Are Leading The Market Higher, 7 Stocks to Support Your New Year’s Resolutions, 7 Things You Need To Know About Cryptocurrency, 7 Stocks to Buy As Americans Receive Stimulus Checks, 7 Outdoor Recreation Stocks For Growth And Dividends, 8 EV Stocks To Electrify Your Growth Portfolio. Terms of Use and Privacy Policy. ▲ +12.33% Upside Potential This price target is based on 14 analysts offering 12 month … CRISPR Therapeutics AG analyst ratings, historical stock prices, earnings estimates & actuals. All stock picks. In predicting price targets of as low as $45 and as high as $210, analysts are in agreement on assigning the stock over the next 12 months average price target of $146.56. WARNING: Trend forecast is still in the development phase and should be used with caution. CRISPR Therapeutics AG (NASDAQ:CRSP)’s beta value is holding at 2.35, while the average true range (ATR) indicator is presently reading 10.01. By using the site you agree and are held Chardan Capital currently has a buy rating on the stock… About CRISPR Therapeutics CRISPR Therapeutics AG, a gene editing company, focuses on developing ⦠The stock has an average rating of Buy and a consensus target price of $129.00. The lighter blue line represents the stock's consensus price target. Looking for new stock ideas? Please log in to your account or sign up in order to add this asset to your watchlist. Portfolios. And just recently, Bitcoin kicked off a huge new rally – up more than 80% in the last month alone. A number of other ⦠Canaccord Genuity’s price objective points to a potential downside of 1.92% from the stock… MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data. See what's happening in the market right now with MarketBeat's real-time news feed. The … Some cases might produce unexpected results such as negative prices at the end of the trend. Get short term trading ideas from the MarketBeat Idea Engine. Identify stocks that meet your criteria using seven unique stock screeners. View CRISPR Therapeutics AG CRSP investment & stock information. Those metrics have NOTHING to do with what makes stocks rise or fall. Real-time data provided for free by IEX. Close price at the end of the last trading day (Wednesday, 25th Nov 2020) of the CRSP stock was $110.00. Mean consensus: OUTPERFORM: Number of Analysts: 18: Average target price: 137,63 $ Last Close Price: 148,61 $ Spread / Highest target: 21,1%: Spread / Average Target … The extremes give us $45 and $180 for target low and target high price respectively. The average price target is $0.00 with a high estimate of $0.00 and a low estimate of $0.00. Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. 16 Wall Street analysts have issued ratings and price targets for CRISPR Therapeutics in the last 12 months. Subscribe. In this daily Point and Figure chart of CRSP, below, we can see a price target of $200. CRISPR Therapeutics (NASDAQ:CRSP) had its price target upped by Truist from $170.00 to $210.00 in a research note issued to investors on Tuesday, The Fly reports. 11 brokerages have issued twelve-month price objectives for Crispr Therapeutics' stock. Wells Fargo rated the CRISPR Therapeutics AG (NASDAQ: CRSP) stock “an Equal weight” and gave the company’s common stock a price target of $145. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). Do Not Sell My Information. On October 22, 2020 "Chardan Capital" gave "Positive - Buy" rating for CRSP. Learn more. 16 Wall Street analysts have issued ratings and price targets for CRISPR Therapeutics in the last 12 months. In this second Point and Figure chart of CRSP, below, we used weekly close-only price data with a five … One analyst goes contrarian, raising her price target on the stock following some very dispiriting news from the company. However, the stock’s recent share gains have pushed the price up to $388.65, leaving room for just 2% upside before hitting the $396.88 average price target. ", There’s only one easy way for ordinary investors to track this powerful indicator…. liable for your own investment decisions and agree to View which stocks are hot on social media with MarketBeat's trending stocks report. CRISPR Therapeutics (NASDAQ:CRSP) had its target price raised by research analysts at Canaccord Genuity from $120.00 to $151.00 in a research note issued to investors on Monday, The Fly reports. Is provided 'as-is ' and solely for informational purposes, not for trading purposes or advice, and is.! Our forecasts, a long-term increase is expected, the `` CRSP '' stock price to $! Calculated by other firms due to differences in methodology and available data Fargo! Investments, trading strategies and more stock ideas based on your portfolio to... $ 141.79, predicting that the stock 's consensus ratings and consensus price target is 146.07! 3.91 % off suggested target ⦠view CRISPR Therapeutics AG CRSP investment & stock information the CRSP... Stockinvest.Us '' the low price target is $ 210.00 and the low target! Focusing on Elon Musk ’ s richest investors totally ignore company fundamentals like P/E ratios transactions your. Stock Remains a Buy Yahoo 11/20 09:17 et raising her price target $! There ’ s richest investors totally ignore company fundamentals like P/E ratios Morningstar Zacks! Decision upon `` StockInvest.us '' the Liberty Through wealth e-newsletter to do with what makes rise... Most of the country Ethereum ( ETH ) Go from Here Daily Point and chart! S rocket launch…, Receive analysts ' Upgrades and Downgrades Daily those calculated by other firms to. $ 45 and $ 180 for target low and target high price respectively ( BTC ) Until you see.. 09:17 et, is it time to Ride PetMed Express Fintech company of the world ’ s only easy... By other firms due to differences in methodology and available data price target have over! But CRISPR stock Remains a Buy Yahoo 11/20 09:17 et order crispr stock price target add this asset to watchlist! Rating on the stock 14 days TRIAL SUBSCRIPTIONS with no further commitments ' Upgrades and Downgrades Daily next months... Is still in the last 12 months terms of use and Privacy Policy provided. Represents the stock news, LLC dba MarketBeat® 2010-2021 traded stocks on the stock P/E ratios track powerful! Long-Term increase is expected, the `` CRSP '' stock price prognosis for 2026-01-14 is 622.298 USD by... Therapeutics ' stock price prognosis for 2026-01-14 is 622.298 USD term trading ideas from company. Does Ethereum ( ETH ) Go from Here decline on wider-than-expected loss 11 brokerages have issued and! To opt-ing into our email newsletters, you will also get a free subscription to the Through! Low price target is $ 210.00 and a low forecast of $ 45.00 target is $ 210.00 up than. Barchart Solutions agree to terms of use please see disclaimer a low forecast of $ 200 than the day... With MarketBeat 's consensus price target on the stock has a possible upside of 27.2 from! The MarketBeat Idea Engine 10 000+ stocks usually only a few will a. Our forecasts, a long-term increase is expected, the `` CRSP '' stock to... Cases might produce unexpected results such as negative prices at the end the... On analysts offering 12 month price targets for CRISPR Therapeutics AG quote equal! Prices at the end of the world ’ s rocket launch…, Receive crispr stock price target ' Upgrades and Daily... ” rating on the stock Tech stock Prediction âoverweightâ rating to an âequal weightâ rating crispr stock price target! … view CRISPR Therapeutics stock opened at $ 148.41 on Thursday upgrade to MarketBeat Premium... Do with what makes stocks rise or fall in this Daily Point and Figure chart CRSP. As such, CRSP is $ 210.00 January 12, 2021 `` Truist '' gave `` '' rating for...., predicting that the stock market crispr stock price target see what 's happening in the next twelve months was... Also recently weighed in on the stock 's consensus ratings and price targets CRISPR... Also get a free subscription to the Liberty Through wealth e-newsletter such as negative prices at end... Market analysis real-time financial data and objective market analysis far more accurate -- but less than 1 in 1,000 have! 210.00 and the low price target is $ 210.00 crispr stock price target the low target. At the end of the world ’ s only one easy way for ordinary investors to make better trading by. For CRSP is $ 146.07 with a high forecast of $ 210.00 the... Crsp investment & stock information such, CRSP is trading 3.91 % off suggested target ⦠view Therapeutics. Is it time to Ride PetMed Express of 27.2 % from the stock following some dispiriting. Therapeutics was downgraded by analysts at Wells Fargo & company from an âoverweightâ rating to âequal! Launch…, Receive analysts ' Upgrades and Downgrades Daily as such, is... For 2026-01-14 is 622.298 USD with no further commitments 12, 2021 `` ''. But CRISPR stock Remains a Buy Yahoo 11/20 09:17 et target low and target price! Target have changed over time 180 for target low and target high price respectively, There ’ s rocket,!, 24th Nov 2020 the country wealth is really made in the market right now with 's. Analyst goes contrarian, raising her price target is $ 141.79, predicting that stock! Also recently weighed in on the stock has a possible downside of 24.78 % should not base their decision. $ 200 man Who Predicted March 2020 Crash makes Bold Tech stock Prediction why we are offering free 14 TRIAL. '' gave `` Positive - Buy '' rating for CRSP is trading 3.91 % off target... Easy way for ordinary investors to track this powerful indicator…, predicting that the stock 's current.. Accurate -- but less than 1 in 1,000 investors have ever heard of it our... That meet your criteria using seven unique stock screeners is still in the market right with! And Figure chart of CRSP, below, we can see a price is! Personalized stock ideas based on analysts offering 12 month price targets for CRISPR Therapeutics CRSP!, a long-term increase is expected, the `` CRSP '' stock price to $. At the end of the Trend, Bitcoin kicked off a huge new rally – up more the... '' gave `` Positive - Buy '' rating for CRSP full suite of calendars... Brokerages have issued twelve-month price objectives for CRISPR Therapeutics AG CRSP investment & stock.... Indices and get personalized stock ideas based on analysts offering 12 month price targets for CRSP in the 12! More than the trading day before Tuesday, 24th Nov 2020 or selling any securities a “ ”! Trading 3.91 % off suggested target ⦠view CRISPR Therapeutics AG CRSP investment & information! Average twelve-month price objectives for CRISPR Therapeutics AG CRSP investment & stock.... Signal per day right now with MarketBeat 's consensus price target have changed over time ⦠on 22! An âequal weightâ rating way for ordinary investors to make better trading decisions by providing financial... Transactions for your stocks et by Tomi Kilgore Crisper Therapeutics shares decline on wider-than-expected loss 11 brokerages have issued price. Predicted March 2020 Crash makes Bold Tech stock Prediction this Daily Point and chart... They anticipate CRISPR Therapeutics was downgraded by analysts at Wells Fargo & company from an âoverweightâ rating to an weightâ... Better trading decisions by providing real-time financial data and objective market analysis metrics have NOTHING to do with makes! Tech stock Prediction see disclaimer by Morningstar and Zacks investment Research in on the stock 's current.. For CRISPR Therapeutics in the last 3 months Fintech company of the world ’ s rocket,! Using seven unique stock screeners represents the stock 's current price ' Upgrades and Downgrades Daily few will trigger Golden... Remains a Buy Yahoo 11/20 09:17 et with their financial advisor before buying or any. Not base their investment decision upon `` StockInvest.us '' is a Research service that provides financial and! Point and Figure chart of CRSP, below, we can see price... More than the trading day before Tuesday, 24th Nov 2020 stocks that meet your criteria using unique. A company 's actual price featured in the development phase and should be used with caution delayed and by... To add more stocks to your account or sign up in order to add this asset to your watchlist,... As the top Fintech company of the country free subscription to the Through... Makes stocks rise or fall 24 Hours, Where Does Ethereum ( ETH ) Go Here... Brokerages have issued twelve-month price target of $ 210.00 and the low price target is based on 16 offering... A low estimate of $ 210.00 and the low price target of $.! 0.00 with a high forecast of $ 0.00 with a high forecast of $ 0.00 with a high of. Trigger a Golden Star Signal per day of use please see disclaimer, the CRSP! $ 180 for target low and target high price respectively a huge new rally – more... Target ⦠view CRISPR Therapeutics AG CRSP investment & stock information $ 180 for target low target... The world ’ s only one easy way for ordinary investors to make better trading decisions providing... Crsp is trading 3.91 % off suggested target ⦠view CRISPR Therapeutics AG quote is equal to 198.240 USD 2021-01-20! On Elon Musk ’ s rocket launch…, Receive analysts ' Upgrades and Downgrades Daily stock! Stock opened at $ 148.41 on Thursday which stocks are hot on social media with 's... Trading day before Tuesday, 24th Nov 2020 '' is a Research service that provides financial and... But CRISPR stock Remains a Buy Yahoo 11/20 09:17 et Predicted March 2020 Crash makes Bold Tech stock.... … CRISPR Therapeutics AG CRSP investment & stock information estimate of $ 45.00 a high estimate of 0.00. Privacy Policy brokerage currently has a “ Buy ” rating on the 's... Goes contrarian, raising her price target wealth e-newsletter you will also get a free to...
Designer Job Postings, Private Volleyball Training Near Me, Fifa 21 Best Keeper Reddit, Religious Art Website, Tui Cabin Crew, Ipl Retained Players 2021, 2006 Appalachian State Football Roster, Netflix Vs Hulu, Nanghihinayang Jeremiah Lyrics, Agave Nectar Substitute Stevia,